NCT01847092View on ClinicalTrials.gov

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

PHASE2CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions

Chronic Kidney DiseaseType 2 Diabetes Mellitus

Interventions

DRUG

AZD1722

DRUG

Placebo

Placebo for AZD1722

Trial Locations (1)

80209

Creekside Endocrine Associates PC, Denver

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Ardelyx

INDUSTRY